PT - JOURNAL ARTICLE AU - Eng, Genghmun TI - The <em>IHME</em> vs Me: Modeling USA CoVID-19 Spread, Early Data to the <em>Fifth Wave</em> AID - 10.1101/2021.08.16.21262150 DP - 2021 Jan 01 TA - medRxiv PG - 2021.08.16.21262150 4099 - http://medrxiv.org/content/early/2021/08/24/2021.08.16.21262150.short 4100 - http://medrxiv.org/content/early/2021/08/24/2021.08.16.21262150.full AB - Epidemiologists have never had such high-quality real-time pandemic data. Modeling CoVID-19 pandemic data became a predictive tool in-stead of an afterwards analysis. How early CoVID-19 model predictions impacted US Government policies and practices is first reviewed here as an important part of the pandemic history. It spurred independent modeling efforts, such as this, to help develop a better understanding of CoVID-19 spread, and to provide a substitute for the IHME (Institute for Health Metrics &amp; Evaluation, U. Washington) 4-month predictions for the expected pandemic evolution, which they had to revise every couple of weeks. Our alternative model, which was developed over the course of several earlier medrxiv.org preprints, is shown here to provide a good description for the entire USA CoVID-19 pandemic to date, covering: (1) the original CoVID-19 wave [3/21/20-6/07/20], (2) the Summer 2020 Resurgence [6/07/20-9/25/20], (3) the large Winter 2020 Resurgence [9/25/20-3/19/21], (4) a small Spring 2021 “Fourth Wave”, [3/19/21-6/07/21], and (5) the present-day Summer 2021 “Fifth Wave” [6/07/21-present], which the USA is now in the midst of. Our analysis of the initial “Fifth Wave” data shows that this wave presently has the capacity to infect virtually all susceptible non-vaccinated persons who practice NO Mask-Wearing and minimal Social Distancing.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNoneFunding StatementNo External Funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No Human Subjects Involved in this Data Analysis. No IRB Approval Needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is in the Public Domain or was maintained by bing.com.